Clinical Ink Selected by Dell to Join Founders 50

Dell Recognizes Clinical Ink as High-Growth Startup Poised for Significant Growth Based on Record of Disrupting Life Sciences With Innovative Technology

WINSTON-SALEM, NC and PHILADELPHIA, PA--(Marketwired - Oct 21, 2014) - Clinical Ink, an innovation-driven eSource solutions company, announced today that it was selected by Dell to join its elite Founders 50 Fall 2014 class. The Founders 50 is an exclusive group of global companies identified by Dell as high-growth startups, poised for significant growth and expansion, based on their record of disrupting industry through innovative products and creative solutions.

"We are honored to be recognized by Dell for disrupting the life sciences industry with our SureSource® technology," said Ed Seguine, CEO, Clinical Ink. "As eSource pioneers, Clinical Ink began with a vision of making paperless clinical trials a reality -- by inextricably linking technology and innovation. Today, this vision is revolutionizing the way clinical trials are conducted to dramatically reduce development costs and timelines."

The most widely used eSource platform in the world, Clinical Ink's SureSource is the first purpose-built solution that streamlines clinical research by eliminating paper documentation. Unlike traditional approaches, SureSource captures trial data electronically on tablets at the time of the patient visit.

Founders 50 selection is the sixth industry recognition Clinical Ink has received in 2014, highlighting its innovative flagship product, SureSource.

Part of the Dell for Entrepreneurs initiative, the Founders 50 recognizes companies with a technology backbone that are on the verge of becoming household names. Founders 50 participants exemplify how innovative technology solutions can be used to effect positive change and catalyze business growth. 

About Clinical Ink
Developers of SureSource® -- the industry's most widely used eSource platform -- Clinical Ink is an innovation-driven eSource solutions company. Our vision is to transform clinical trials -- from Start to Submit™ -- by creating a completely 'paperless' clinical trial platform. Clinical Ink maintains offices in Winston-Salem, NC and Philadelphia, PA. Additional information is available at or toll-free 1-800-301-5033.

About Dell
Dell Inc. listens to customers and delivers innovative technology and services that give them the power to do more. For more information, visit

Contact Information:

Media Contact:
Alicia Maguire
Clinical Ink
336.464.0696 (x812)